Skip to main content

Part of the book series: Developments in Cardiovascular Medicine ((DICM,volume 240))

  • 415 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Suggested readings

  1. Jennings RB, Steenbergen C Jr, Reimer KA. Myocardial ischemia and reperfusion. Monogr Pathol. 1995; 37:47–80.

    PubMed  CAS  Google Scholar 

  2. Reimer KA, Vander Heide RS, Jennings RB. Ischemic preconditioning slows ischemic metabolism and limits myocardial infarct size. Ann N Y Acad Sci. 1994; 723:99–115.

    PubMed  CAS  Google Scholar 

  3. Jennings RB, Reimer KA. The cell biology of acute myocardial ischemia. Annu Rev Med. 1991; 42:225–46.

    Article  PubMed  CAS  Google Scholar 

  4. Reimer KA, Jennings RB. The “wavefront phenomenon” of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest. 1979; 40:633–44.

    PubMed  CAS  Google Scholar 

  5. Brockington CD, Lyden PD. Criteria for selection of older patients for thrombolytic therapy. Clin Geriatr Med. 1999; 15:721–39.

    PubMed  CAS  Google Scholar 

  6. Hamm CW. New serum markers for acute myocardial infarction. N Engl J Med. 1994; 331:607–8.

    PubMed  CAS  Google Scholar 

  7. Straznicky IT, White HD. Thrombolytic therapy for acute myocardial infarction in the elderly. Coron Artery Dis. 2000; 11:299–304.

    Article  PubMed  CAS  Google Scholar 

  8. Zhao M, Zhang H, Robinson TF, Factor SM, Sonneblick H, Eng C. Profound structural alterations of the extracellular collagen matrix in postischemic dysfunctional (“stunned”) but viable myocardium. J Am Coll Cardiol 1987; 10:1322–34.

    Article  PubMed  CAS  Google Scholar 

  9. Factor SM, Bache R. “Pathophysiology of Myocardial Ischemia”. In Hurt’s The Heart. Ninth Edition. Alexander WR, Schlant RC, and Fuster V eds. McGraw-Hill Co, Inc., 1998.

    Google Scholar 

Suggested readings

  1. Levine GN, Ali MN. The role of percutaneous revascularization in the treatment of ischemic heart disease: insights from published reports and randomized clinical trials. Chest. 1997; 112:805–21.

    PubMed  CAS  Google Scholar 

  2. Kawasuji M, Sakakibara N, Takemura H, Tedoriya T, Ushijima T, Watanabe Y. Is internal thoracic artery grafting suitable for a moderately stenotic coronary artery? J Thorac Cardiovasc Surg. 1996; 112:253–9.

    PubMed  CAS  Google Scholar 

  3. Jensen J, Eriksson SV, Lindvall B, Lundin P, Sylven C. Women react with more myocardial ischemia and angina pectoris during elective percutaneous transluminal coronary angioplasty. Coron Artery Dis. 2000; 11:527–35.

    PubMed  CAS  Google Scholar 

  4. Friesinger GC, Ryan TJ. Coronary heart disease. Stable and unstable syndromes. Cardiol Clin. 1999; 17:93–122.

    PubMed  CAS  Google Scholar 

  5. Cishek MB, Gershony G. Roles of percutaneous transluminal coronary angioplasty and bypass graft surgery for the treatment of coronary artery disease. Am Heart J. 1996; 131:1012–7.

    Article  PubMed  CAS  Google Scholar 

  6. Tennant M, McGeachie JK. A biological basis for re-stenosis after percutaneous transluminal angioplasty: possible underlying mechanisms. Aust N Z J Surg. 1992; 62:135-4.

    Google Scholar 

  7. Weiner DA. Significance of silent myocardial ischemia after coronary artery bypass surgery. Am J Cardiol. 1992; 70:35F–38F.

    Article  PubMed  CAS  Google Scholar 

  8. Factor SM, Minase T, Cho S, Fein F, Capasso JM, Sonneblick EH. Coronary microvascular abnormalities in the hypertensive-diabetic rat. A cause of cardiomyopathy? Am J Pathol 1984; 116:9–20.

    PubMed  CAS  Google Scholar 

Suggested readings

  1. Nienaber CA, Von Kodolitsch Y. Therapeutic management of patients with Marfan syndrome: focus on cardiovascular involvement. Cardiol Rev. 1999; 7:332–41.

    PubMed  CAS  Google Scholar 

  2. Libby P, Sukhova G, Lee RT, Liao JK Molecular biology of atherosclerosis. Int J Cardiol. 1997; 62(Suppl 2):S23–9.

    Google Scholar 

  3. Leopold JA, Loscalzo J. Clinical importance of understanding vascular biology Cardiol Rev. 2000; 8:115–23.

    Article  PubMed  CAS  Google Scholar 

  4. Samman B, Korr KS, Katz AS, Parisi AF. Pitfalls in the diagnosis and management of papillary muscle rupture: a study of four cases and review of the literature. Clin Cardiol. 1995; 18:591–6.

    Article  PubMed  CAS  Google Scholar 

  5. Reeder GS. Identification and treatment of complications of myocardial infarction. Mayo Clin Proc. 1995; 70:880–4.

    PubMed  CAS  Google Scholar 

  6. Buda AJ. The role of echocardiography in the evaluation of mechanical complications of acute myocardial infarction. Circulation. 1991; 84 (3 Suppl):I109–21.

    PubMed  CAS  Google Scholar 

  7. Prieto A, Eisenberg J, Thakur RK. Nonarrhythmic complications of acute myocardial infarction. Emerg Med Clin North Am. 2001; 19: 397–415.

    Article  PubMed  CAS  Google Scholar 

  8. Robinson TF, Geraci MA, Sonneblick EH, Factor SM. Coiled perimysial fibers of papillary muscle in rat heart; morphology, distribution, and changes in configuration. Circ Res 1988; 63:577–92.

    PubMed  CAS  Google Scholar 

Suggested readings

  1. Villablanca AC, McDonald JM; Rutledge JC. Smoking and cardiovascular disease. Clin Chest Med. 2000; 21:159–72.

    Article  PubMed  CAS  Google Scholar 

  2. Reimer KA, Jennings RB. Biologic basis for limitation of infarct size. Adv Exp Med Biol. 1986; 194:315–30.

    PubMed  CAS  Google Scholar 

  3. Ravn HB, Falk E. Histopathology of plaque rupture. Cardiol Clin. 1999; 17:263–70.

    PubMed  CAS  Google Scholar 

  4. Schroeder AP, Falk E. Pathophysiology and inflammatory aspects of plaque rupture. Cardiol Clin. 1996; 14:211–20.

    PubMed  CAS  Google Scholar 

  5. Becker RC, Bovill EG, Seghatchian MJ, Samama MM. Pathobiology of thrombin in acute coronary syndromes. Am Heart J. 1998; 136:S19–31

    Article  Google Scholar 

  6. Stern S, Cohn PF, Pepine CJ. Silent myocardial ischemia. Curr Probl Cardiol. 1993; 18:301–59.

    Article  PubMed  CAS  Google Scholar 

  7. Okun EM, Factor SM, Kirk ES. End-capillary loops in the heart: An explanation for discrete myocardial infarctions without border zones. Science 1979; 206:565–67.

    PubMed  CAS  Google Scholar 

  8. Factor SM, Okun EM, Kirk ES. The histological lateral border of acute canine myocardial infarction: a function of the microcirculation. Circ Res 1981; 48:640–49.

    PubMed  CAS  Google Scholar 

  9. Factor SM, Okun EM, Minase T, Kirk ES. The microcirculation of the human heart: end capillary loops with discrete perfusion fields. Circulation 1982; 66:1241–48.

    PubMed  CAS  Google Scholar 

  10. Forman R, Cho S, Factor SM, Kirk ES. Acute myocardial infarct extension into a previously preserved subendocardial region at risk in dogs and patients. Circulation 1982; 67:117–24.

    Google Scholar 

Suggested readings

  1. Hirsh J. Coronary thrombolysis: hemorrhagic complications. Can J Cardiol 1993; 9:505–11.

    PubMed  CAS  Google Scholar 

  2. Sleight P. Thrombolysis: state of the art. Eur Heart J 1993; Suppl G:41–7.

    Google Scholar 

  3. Simoons ML. Risk-benefit of thrombolysis. Cardiol Clin 1995; 13:339–45.

    PubMed  CAS  Google Scholar 

  4. Jafri SM, Walters BL, Borzak S. Medical therapy of acute myocardial infarction: Part I. Role of thrombolytic and antithrombotic therapy. J Intensive Care Med 1995; 10:54–63.

    PubMed  CAS  Google Scholar 

  5. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists’ (FTT) Collaborative Group. Lancet 1994; 343:311–22.

    PubMed  Google Scholar 

Suggested readings

  1. Elming H, Kober L. Spontaneous coronary artery dissection. Case report and literature review. Scand Cardiovasc J. 1999; 33:175–9.

    PubMed  CAS  Google Scholar 

  2. Atay Y, Yagdi T, Turkoglu C, Altintig A, Buket S. Spontaneous dissection of the left main coronary artery: a case report and review of the literature. J Card Surg. 1996; 11:371–5.

    PubMed  CAS  Google Scholar 

  3. Waller BF, Fry ET, Hermiller JB, Peters T, Slack JD. Nonatherosclerotic causes of coronary artery narrowing—Part II. Clin Cardiol. 1996; 19:587–91.

    PubMed  CAS  Google Scholar 

  4. Jouriles NJ. Atypical chest pain. Emerg Med Clin North Am. 1998 Nov; 16:717–40.

    Google Scholar 

  5. Borczuk AC; van Hoeven KH; Factor SM. Review and hypothesis: the eosinophil and peripartum heart disease (myocarditis and coronary artery dissection)—coincidence or pathogenetic significance? Cardiovasc Res. 1997; 33:527–32.

    Article  PubMed  CAS  Google Scholar 

  6. Hahn IH, Hoffman RS. Cocaine use and acute myocardial infarction. Emerg Med Clin North Am. 2001; 19:493–510.

    Article  PubMed  CAS  Google Scholar 

  7. Rump AF, Theisohn M, Klaus W. The pathophysiology of cocaine cardiotoxicity. Forensic Sci Int. 1995; 71:103–15.

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Kluwer Academic Publishers

About this chapter

Cite this chapter

(2002). Atherosclerotic Heart Disease and Ischemia. In: Handbook of Pathology and Pathophysiology of Cardiovascular Disease. Developments in Cardiovascular Medicine, vol 240. Springer, Boston, MA. https://doi.org/10.1007/0-306-47575-8_2

Download citation

  • DOI: https://doi.org/10.1007/0-306-47575-8_2

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-7923-7542-5

  • Online ISBN: 978-0-306-47575-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics